Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
2.570
0.00 (0.00%)
At close: Apr 3, 2025, 4:00 PM
2.508
-0.062 (-2.41%)
Pre-market: Apr 4, 2025, 4:00 AM EDT
Vivos Therapeutics Revenue
In the year 2024, Vivos Therapeutics had annual revenue of $15.03M with 8.91% growth. Vivos Therapeutics had revenue of $3.70M in the quarter ending December 31, 2024, with 13.85% growth.
Revenue (ttm)
$15.03M
Revenue Growth
+8.91%
P/S Ratio
0.86
Revenue / Employee
$122,203
Employees
123
Market Cap
15.14M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
VVOS News
- 3 days ago - Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update - GlobeNewsWire
- 6 days ago - Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call - GlobeNewsWire
- 3 months ago - Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 5 months ago - Vivos Therapeutics, Inc. (VVOS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call - GlobeNewsWire
- 6 months ago - Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association - GlobeNewsWire
- 7 months ago - Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring - GlobeNewsWire